A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...

The FDA has approved Journavx, a new non-opioid pain medication designed to reduce addiction and overdose risks.

Suzetrigine, to be sold under the brand name Journavx, is the first new type of pain medicine approved by the FDA in more ...

Nerve pain refers to painful sensations around the nerves. Various treatment options are available, including anticonvulsants, certain antidepressants, mild opioids, and some topical treatments.

Best TENS machines for effective chronic pain relief - Discover the benefits and drawbacks of using electrical nerve ...

Sensory stimulation at 50 Hz, 0.3–0.7 V is desirable, followed by motor stimulation at 2 Hz up to 2 V to confirm that there is no motor nerve ... treatment of chronic lumbar radicular pain.

The US FDA has approved Journavx, a new pain reliever without the risks of addiction or overdose linked to drugs like Vicodin and OxyContin.

While New Orleans prepares for the excitement of the big game, it’s important to remember that sports injuries aren’t limited to the professionals. High school athletes, weekend warriors, and generall ...

A new class of non-opioid drugs treats pain by blocking signals before they reach the brain, reducing the risk of addiction.

A non-opioid painkiller from Vertex Pharmaceuticals could become a blockbuster, but questions remain on whether it will prove safe and effective for chronic pain.

The U.S. Food and Drug Administration (FDA) on Thursday approved Journavx, the first new class of pain medication in more ...

The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals' Journavx for short-term pain that often ...